文献速递神经肿瘤神经重症

原发性恶性脑肿瘤患者与其他癌症患者死亡质量的比较:日本全国性丧亲调查结果

Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan.
PubMed 文献 · J Neurooncol · 2022-04-18

本研究为日本两项全国性多中心丧亲调查的二次分析,纳入14171名丧亲家属(其中160例恶性脑肿瘤患者),采用良好死亡量表(GDI)评估死亡质量。恶性脑肿瘤患者GDI总分显著低于其他癌症患者(p<0.0001),且在5个条目上得分显著更低。结论提示恶性脑肿瘤患者死亡质量较低,建议根据其特点重新审视照护。

要点

  • 恶性脑肿瘤患者GDI总分显著低于其他癌症患者(p<0.0001)。
  • 5个GDI条目得分显著更低:能待在喜欢的地方、信任医生、不成为他人负担、日常活动独立、觉得生活有价值。
  • 恶性脑肿瘤患者较其他患者更年轻(p<0.0001),临终期在姑息治疗病房住院时间更长(p<0.0001)。

核心结论

  • 恶性脑肿瘤患者的死亡质量低于其他癌症患者,提示需根据其特点重新审视照护。

研究设计与样本

  • 日本两项全国性多中心姑息治疗病房丧亲调查数据的二次分析,纳入14171名丧亲家属,其中160例为恶性脑肿瘤患者。

主要发现

  • 恶性脑肿瘤患者比其他癌症患者更年轻(p<0.0001),临终期在姑息治疗病房住院时间更长(p<0.0001)。
  • 恶性脑肿瘤患者GDI总分显著低于其他癌症患者(p<0.0001)。
  • 恶性脑肿瘤组在「能待在喜欢的地方」条目得分显著低于其他癌症组(p=0.03)。
  • 恶性脑肿瘤组在「信任医生」条目得分显著低于其他癌症组(p=0.003)。
  • 恶性脑肿瘤组在「不成为他人负担」条目得分显著低于其他癌症组(p=0.01)。

关键数值与推荐

  • 采用良好死亡量表(GDI)评估死亡质量。

临床怎么用

  • 作者认为,应根据恶性脑肿瘤患者的特点重新审视其照护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: No studies have investigated the association between malignant brain tumor and the quality of dying, which is an important outcome in end-of-life care. This study aimed to clarify whether the quality of dying and related factors in patients with malignant brain tumor differ from those in patients with other malignant diseases. METHODS: This was a secondary analysis of data collected by two nationwide, multicenter, bereavement surveys of palliative care units in Japan. This analysis included 14,171 bereaved family members (160 patients with malignant brain tumors). The quality of dying was examined using the good death inventory (GDI), a validated tool widely used in palliative care settings. RESULTS: Patients with malignant brain tumors were younger (p < 0.0001) and had a longer palliative care unit stay during their end-of-life (p < 0.0001) than others. The total GDI score was significantly lower in patients with malignant brain tumors than others (p < 0.0001). Five GDI items were significantly lower in the malignant brain tumor group than other cancer group: "Being able to stay in one's favorite place" (p = 0.03); "Trusting the physician" (p = 0.003); "Not being a burden to others" (p = 0.01); "Being independent in daily activities" (p = 0.01); and "Feeling that one's life is worth living" (p = 0.001). CONCLUSION: This study showed that the quality of dying of patients with malignant brain tumors was lower compared to other cancers, suggesting the need to review care for patients with malignant brain tumors based on their characteristics.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Aoyama M, Masukawa K, Sugiyama I, et al. Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan. J Neurooncol. 2022. PMID: 35435613. doi:10.1007/s11060-022-04013-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。